Brief: Neumora Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update
14/08/2026 12:28
BRIEF-Neumora Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update Aug 14 (Reuters) - Neumora Therapeutics Inc NMRA.O:
NEUMORA THERAPEUTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
NEUMORA THERAPEUTICS - APPOINTS JOSHUA PINTO AS PRESIDENT AND CEO AND BOARD MEMBER
NEUMORA THERAPEUTICS - PAUL L. BERNS TO SERVE AS EXECUTIVE CHAIR
NEUMORA THERAPEUTICS - Q2 2026 NET LOSS $43.10 MILLION VERSUS $52.70 MILLION IN Q2 2025
Source text: ID:nGNX5jl6CN
Further company coverage: NMRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neumora Therapeutics
See all newsNeumora Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Neumora Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update
Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex